SUPPORTING YOUR ONCOLOGICAL JOURNEY

Integrative oncology formulas for supporting cancer patients’ needs throughout their oncology journey.

Dr. Donald Abrams - Integrative Oncologists, UCSF

As presented at:

42%

of Breast Cancer patients use Cannabis as an Integrative Oncology treatment.*

*According to a 2022 study on 600 breast cancer patients | https://pubmed.ncbi.nlm.nih.gov/34636036/

OUR SOLUTIONS ARE GROUNDED IN SCIENCE:

2021
In-Vitro
2022
In-Vivo
2023
Ex-Vivo
2024
Commercialization
and Clinical Trials
 

Goal

Providing cancer patients and their HCPs with sufficient evidence to trust our solutions and integrate them into the oncology treatment protocol in a comprehensive manner.

As seen in:

Integrative oncology formulas for supporting cancer patients’ needs throughout their oncology journey

Our mission is to develop the optimal integrative formulas for supporting each cancer patient according to his or her needs throughout the oncology journey. 

We aim to provide the cancer patients and their healthcare providers with sufficient evidence to trust our solutions and to integrate them into the oncology treatment protocol in a comprehensive manner.

Our solutions are intended to meet the needs of the 50% of cancer patients in the US who currently use integrative products, such as cannabis and mushroom extracts, along with conventional cancer treatment.